Skip to search formSkip to main contentSkip to account menu

Cutaneous Assessment Tool

Known as: CAT 
An assessment of a wide range of cutaneous manifestations reflecting activity and damage from idiopathic inflammatory myopathy in children and adults… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2020
Review
2020
Background Localized Scleroderma (LoS) is an autoimmune connective tissue disease that affects skin and less commonly… 
2018
2018
The disease phase in localized scleroderma (LoS) is commonly assessed by clinical investigation using the LoS cutaneous… 
2017
2017
Objectives—The Cutaneous Assessment Tool (CAT) is a comprehensive, semi-quantitative tool for the assessment of skin disease in… 
2016
2016
To compare the abbreviated Cutaneous Assessment Tool (CAT), Disease Activity Score (DAS), and Myositis Intention to Treat… 
2014
2014
Localized scleroderma (LS) is an autoimmune, inflammatory disease of the skin and subdermal tissues, resulting in fibrosis and… 
Review
2012
Review
2012
Purpose of reviewMorphea, also known as localized scleroderma, is a disorder of excessive collagen deposition leading to… 
Highly Cited
2008
Highly Cited
2008
Background  Reliable and validated measures of skin disease severity are needed for cutaneous dermatomyositis (DM). Cutaneous… 
2008
2008
OBJECTIVE The Cutaneous Assessment Tool (CAT) is a comprehensive, semiquantitative tool for the assessment of skin disease in… 
2008
2008
OBJECTIVE To provide preliminary validation of the Cutaneous Assessment Tool (CAT), a new tool to assess cutaneous manifestations… 
2007
2007
OBJECTIVES Clinical care and therapeutic trials in idiopathic inflammatory myopathies (IIM) require accurate and consistent…